Disclaimer for the US market

The products and information provided on this website are intended for healthcare professionals. These products are not for sale or distribution in the United States and statements made regarding these products have not been evaluated by the U.S. Food and Drug Administration (FDA). The efficacy of these products has not been confirmed by FDA-approved research and these products are therefore not intended to diagnose, treat, cure or prevent any disease. All information presented here is for general information purposes only and not meant as a substitute for or alternative to advice from healthcare practitioners. The Federal Food, Drug and Cosmetic Act requires this notice.

Neither the Company nor its representatives is providing any medical advice, and none should be inferred, from any ideas, suggestions, testimonials or other information set forth on this website or in other Company materials or provided over the phone, in the mail, in product packaging, or in email correspondence. This website may contain links to third-party websites. The Company provides these links as a convenience only and does not endorse any of these sites. The Company is not responsible for the content of, and does not make any representations regarding the materials on, such linked third-party websites. If you decide to access or rely on information at linked third-party website, you do so at our own risk. Our terms and conditions, including disclaimers, are more fully set forth in our Terms of Use, Privacy Policy and Terms of Online Sales.

EACTS 2023 – CARL. Raising the bar of ECPR

to achieve neurologic intact survival after refractory cardiac arrest.  

At the 37th EACTS Annual Meeting, which took place in Vienna from October 4 – 7 under the slogan “Raising the Bar ­– Innovate, Discover, Educate”, we experienced a significant increase in the number of physicians, perfusionists, distributors and partners compared to the previous year. This indicates that the CARL Community is growing rapidly.

The CARL. Community is growing.

A special highlight of this year’s event was the awarding of four of the various research-based approaches to improving patient outcomes, presented at the first EACTS Innovation Summit in Paris in April 2023.


Representing the Medical Center – University of Freiburg, Georg Trummer of the Department of Cardiovascular Surgery was awarded for the project “Expanded resuscitation and multi-organ repairs are the next level of ECPR: controlled and automated whole-body reperfusion highly increases the chances of cardiac arrest patients while minimizing damage to brain and other organs”.